TaiGen Biotechnology Co., Ltd.

TaiGen Biotechnology Company Ltd. is a research-based and product-driven biopharmaceutical company based in Taiwan. The company focuses on the discovery, development and commercialization of drugs for use in oncology and in the treatment of immune disorders and infectious diseases. Under the leadership of an executive team with decades of experience in major international pharmaceutical and biotech companies and with a talented R&D staff, TaiGen is positioned to become a top global pharmaceutical company and a leader in Asia. TaiGen currently has operations in Taiwan, China, and the U.S.TaiGen was founded in May 2001. In February 2002, TaiGen opened its state-of-the-art 40,000 square foot corporate R&D facility in Taiwan’s Nei-hu industrial park, which is in the center of a cluster of top research institutes. TaiGen currently employs 96 people, including 75 scientists. In October 2004, TaiGen established a subsidiary in China called TaiGen Biopharmaceuticals Co. (Beijing), Ltd. to conduct clinical trials and drug registration.

Contact Details: 7F,138 Shin Ming Rd. Neihu Dist. Taipei 114 R.O.C. Taiwan Tel: 886-2-81777072 Fax: 886-2-27963606 Email: service@taigenbiotech.com.tw WWW: www.taigenbiotech.com/

Press Releases on TaiGen Biotechnology Co., Ltd.:
Excellent Stem Cell Mobilization and Safety Profile for TG-0054	28th September, 2009	TaiGen Biotechnology Co., Ltd.	TAIPEI, Taiwan, Sept. 28 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd. announced today that in a phase 1 study in healthy volunteers TG-0054, a chemokine receptor CXCR4 antagonist, was well
TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing	20th January, 2009	TaiGen Biotechnology Co., Ltd.	TAIPEI, Taiwan, Jan. 20 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd., a privately-held pharmaceutical company focused on developing drugs to treat infectious diseases, cancer and diabetes

BioNews Results for TaiGen Biotechnology Co., Ltd.:
Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education	PR Newswire:  Nov 23 2009 12:47AM Matching: biotechnology
Reportlinker Adds Biotechnology Reagents - A Global Market Perspective	PR Newswire:  Nov 23 2009 12:46AM Matching: biotechnology
Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute f	PR Newswire:  Nov 23 2009 12:44AM Matching: biotechnology
Business: A Birthing Ground For Bioscience	CBS 4 Denver:  Nov 22 2009 8:05PM Matching: biotechnology
Life Sciences: Research from National University of Singapore broadens understanding of life sciences	NewsRX:  Nov 22 2009 10:33AM Matching: biotechnology
Promote your company here: BioNewsCast - Press Release Distribution	→View more TaiGen Biotechnology Co., Ltd. news.

TaiGen Biotechnology Co., Ltd. Patents:
US Patent No.	Title
7504422	Polyamine compounds
7462594	Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
7378524	Aminoquinoline compounds

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 409 times since April 2007, the link to the organisation's website has been followed 76 times

Recent Search Terms used to find this page: TG-0054 patent | TaiGen Biotechnology Co. Ltd. | Who did taigen biotechnology co. ltd. began | taigen biotechnology co. ltd. | taiwan biotechnology 2009 | TaiGen Biopharmaceuticals | taigen biotechnology | taigen biopoharmaceuticals | taigen biotechnology | TaiGen Biopharmaceuticals Co. Beijing Ltd. | .

Search for more companies in Taipei

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for TaiGen Biotechnology Co., Ltd.